SGX queries Biolidics on timing of disclosure that authorities had approved its Covid-19 test kits

Singapore

BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority (HSA) after it was certain that the kits could be commercialised.

In an exchange filing on Thursday, the firm also said it only received approval for the product to be manufactured and marketed under its own brand some time later.